Pneumococcal Conjugate Vaccine Breakthrough Infections: 2001–2016

[Figure: see text] BACKGROUND: Most countries use 3-dose pneumococcal conjugate vaccine (PCV) schedules; a 4-dose (3 primary and 1 booster) schedule is licensed for US infants. We evaluated the invasive pneumococcal disease (IPD) breakthrough infection incidence in children receiving 2 vs 3 primary...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Pediatrics
Main Authors: Adebanjo, Tolulope A., Pondo, Tracy, Yankey, David, Hill, Holly A., Gierke, Ryan, Apostol, Mirasol, Barnes, Meghan, Petit, Susan, Farley, Monica, Harrison, Lee H., Holtzman, Corinne, Baumbach, Joan, Bennett, Nancy, McGuire, Suzanne, Thomas, Ann, Schaffner, William, Beall, Bernard, Whitney, Cynthia G., Pilishvili, Tamara
Formato: Artigo
Idioma:Inglês
Publicado em: American Academy of Pediatrics 2020
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7055927/
https://ncbi.nlm.nih.gov/pubmed/32054822
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1542/peds.2019-0836
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados